2023

Hrbáček J., Hanáček V., Kadlečková D., Cirbusová A., Čermák P., Tachezy R., Zachoval R., Saláková M. (2023): Urinary shedding of common DNA viruses and their possible association with bladder cancer: a qPCR-based study. Neoplasma 70 (2): 311-318. [PubMed]

Kadlečková D., Vinkler M., Tachezy R., Saláková M. (2023): Genome sequence of parvovirus from budgerigar (Melopsittacus undulatus). Microbiol. Resour. Announc. e0045323. [PubMed]

Kliegr T., Jarkovský J., Jiřincová H., Kuchař J., Karel T., Chudán D., Vojíř S., Zavřel M., Šanca O., Tachezy R. (2023): Can variants, reinfection, symptoms and test types affect COVID-19 diagnostic performance? A large-scale retrospective study of AG-RDTs during circulation of Delta and Omicron variants, Czechia, December 2021 to February 2022. Eurosurveillance 28 (38): 2200938. [PubMed]

Němcová J., Černá K., Šíma R., Kinkorová Luňáčková I., Rob F., Martínek P., Bouda J., Šmahelová J., Ondič O. (2023): Metylačni analyza jako pomocný nástroj v cytologické diagnostice vzácnějších anogenitálních lézí – pilotní studie. Česko-slovenská patologie 1: 26-31.

Šmahel M., Nunvář J. (2023): Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses. Virol. J. 20 (1): 287. [PubMed]

2022

Kadlečková D., Tachezy R., Erban T., Deboutte W., Nunvář J., Saláková M., Matthijnssens J. (2022): The virome of healthy honey bee colonies: ubiquitous occurrence of known and new viruses in bee populations. mSystems: e0007222. [PubMed]

Kliegr T., Jarkovský J., Jiřincová H., Kuchař J., Karel T., Tachezy R. (2022): Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021. Eurosurveillance 27 (33): 2200070. [PubMed]

Němcová J., Riegert J., Černá K., Rob F., Šmahelová J., Hercogová J.T., Martínek P., Ondič O. (2022): Prevalence of oral and anal human papillomavirus infection in Czech predominantly Human immunodeficiency virus-positive men having sex with men - data from a previously unreported population. Int. J. STD AIDS 33 (12): 1054-1064. [PubMed]

Pokrývková B., Grega M., Klozar J., Vencálek O., Nunvář J., Tachezy R. (2022): PD1⁺CD8⁺ cells are an independent prognostic marker in patients with head and neck cancer. Biomedicines 10 (11): 2794. [PubMed]

Rob F., Hugo J., Saláková M., Šmahelová J., Gkalpakiotis S., Boháč P., Tachezy R. (2022): Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy. Dermatol. Ther. 35 (10): e15735. [PubMed]

Saláková M., Ludvíková V., Hamšíková E., Kolářová M., Šroller V., Viklický O., Wohlfahrtová M. (2022): retransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia. Front Immunol. 13: 929946. [PubMed]

Šmahelová J., Hamšíková E., Ludvíková V., Vydrová J., Traboulsi J., Vencálek O., Lukeš P., Tachezy R. (2022): Outcomes after human papillomavirus vaccination in patients with recurrent respiratory papillomatosis: a nonrandomized clinical trial. JAMA Otolaryngol.-Head Neck Surg. 148 (7): 654-661. [PubMed]

Zahradník J., Nunvář J., Schreiber G. (2022): Perspectives: SARS-CoV-2 spike convergent evolution as a guide to explore adaptive advantage. Front. Cell. Infect. Microbiol. 12: 748948. [PubMed]

2021

Němcová J., Černá K., Rob F., Šmahelová J., Třešňák Hercogová J., Marx J., Traxmandlová I., Ondič O. (2021): Prevalence of high-risk human papillomavirus DNA and mRNA and its association with abnormal anal cytology in the Czech male anal cancer screening cohort. Diagn. Cytopathol. 49 (11): 1188-1195. [PubMed]

Nunvář J., Pagáčová L., Vojtěchová Z., Azevedo N.T.D., Šmahelová J., Saláková M., Tachezy R. (2021): Lack of conserved miRNA deregulation in HPV-induced squamous cell carcinomas. Biomolecules. 11 (5): 764. [MDPI]

Piataková A., Poláková I., Šmahelová J., Johari S.D., Nunvář J., Šmahel M. (2021): Distinct responsiveness of tumor-associated macrophages to immunotherapy of tumors with different mechanisms of Major Histocompatibility Complex Class I downregulation. Cancers 13 (12): 3057 [MDPI]

Saláková M. (2021): Možnosti diagnostiky lidských polyomavirů v klinické praxi [Diagnostic options for human polyomaviruses in clinical practice]. Epidemiol. Mikrobiol. Imunol. 70 (3): 178-188. [PubMed] [In Czech]

Šťastná-Marková M., Hamšíková E., Hainz P., Hubáček P., Kroutilová M., Kryštofová J., Ludvíková V., Musil J., Pecherková P., Saláková M., Šroller V., Vydra J., Němečková Š. (2021): Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk for BK virus-associated haemorrhagic cystitis after allogeneic HSCT. Vaccines 9 (11): 1226 [PubMed]

Zahradník J., Nunvář J., Schreiber G. (2021): SARS-CoV-2 convergent evolution as a guide to explore adaptive advantage. doi:10.1101/2021.05.24.445534. [bioRxiv]

2020

Kanwal M., Šmahel M., Olsen M., Šmahelová J., Tachezy R. (2020): Aspartate β-hydroxylase as a target for cancer therapy. J. Exp. Clin. Cancer Res. 39 (1): 163. [PubMed]

Maléřová S., Hejtmánková A., Hamšíková E., Saláková M., Šmahelová J., Klozar J., Tachezy R. (2020): Prevalence and risk factors for oral HPV in healthy population, in central Europe. Anticancer Res. 40 (3): 1597-1604. [PubMed]

Maléřová S., Kalfeřt D., Grega M., Tachezy R., Klozar J. (2020): The significance of p16 protein expression in oral squamous cell carcinoma. Epidemiol. Mikrobiol. Imunol. 69 (2): 64-72. [Pro lékaře]

2019

Božinović K., Sabol I., Dediol E., Milutin Gašperov N., Manojlović S., Vojtěchová Z., Tachezy R., Grce M. (2019): Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer. Sci. Rep. 9 (1): 2306 [PubMed]

Poláková I., Pelák O., Thürner D., Pokrývková B., Tachezy R., Kalina T., Šmahel M. (2019): Implementation of mass cytometry for immunoprofiling of patients with solid tumors. J. Immunol. Res. 2019: 6705949 [PubMed]

Simonidesová S., Hamšíková E., Ludvíková V., Klozar J., Vencálek O., Tachezy R. (2019): Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors. J. Surg. Oncol. 120 (2): 117-124 [PubMed]

2018

Grzelak A., Poláková I., Šmahelová J., Vacková J., Pekarčíková L., Tachezy R., Šmahel M. (2018): Experimental combined immunotherapy of tumours with Major Histocompatibility Complex Class I downregulation. Int. J. Mol. Sci. 19 (11): pii: E369.3 [PubMed]

Hladíková K., Partlová S., Koucký V., Bouček J., Fonteneau J.F., Zábrodský M., Tachezy R., Grega M., Špíšek M., Fialová A. (2018): Dysfunction of HPV16-specific CD8+ T cells derived from oropharyngeal tumors is related to the expression of Tim-3 but not PD-1. Oral Oncol. 82: 75-82. [PubMed]

Saláková M., Košlabová E., Grega M., Šmahelová J., Klozar J., Vencálek O., Tachezy R. (2018): Mucosal and skin HPV types in tumour-free tonsils and tonsillar tumours. Neoplasma 65 (2): 278-286.  [PubMed]

Simonidesová S., Hamšíková E., Klozar J., Tachezy R. (2018): The prevalence of oral HPV infection in healthy populations: A systematic review with a focus on European populations. Epidemiol. Mikrobiol. Imunol. 67 (4): 175-183. [PubMed]

Vojtěchová Z., Tachezy R. (2018): The role of miRNAs in virus-mediated oncogenesis. Int. J. Mol. Sci. 19 (4): E1217. [PubMed]

2017

Hamšíková E., Šmahelová J., Ludvíková V., Saláková M., Rychlá J., Skřenková J., Rob L., Tachezy R. (2017): The prevalence of HPV infections in HPV-vaccinated women from the general population. APMIS 125 (6): 585–595. [PubMed]

Rob F., Tachezy R., Pichlík T., Škapa P., Rob L., Hamšíková E., Šmahelová J., Hercogová J. (2017): Concordance of HPV-DNA in cervical dysplasia or genital warts in women and their monogamous long-term male partners. J. Med. Virol. 89 (9): 1662-1670. [PubMed]

Rob F., Tachezy R., Pichlík T., Rob L., Kružicová Z., Hamšíková E., Šmahelová J., Hercogová J. (2017): High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts—Another reason for HPV vaccination of boys. Dermatol. Ther. 30: e12435. [Wiley Online Library]

Šmahelová J., Kaštánková I^., Poláková K.M., Klamová H., Zemanová K., Tachezy R., Hamšíková E., Šmahel M. (2017): Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia. Oncol. Rep. 37 (1): 547-554. [PubMed]

Vojtěchová Z., Zavadil J., Klozar J., Grega M., Tachezy R. (2017): Comparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumors. PLoS ONE 12 (6): e0179645. [PubMed]

2016

Jelen M.M., Chen Z., Kocjan B.J., Hošnjak L., Burt F.J., Chan P.K., Chouhy D., Combrinck C.E., Estrade C., Fiander A., Garland S.M., Giri A.A., González J.V., Gröning A., Hibbitts S., Luk T.N., Marinic K., Matsukura T., Neumann A., Oštrbenk A., Picconi M.A., Sagadin M., Sahli R., Seedat R.Y., Seme K., Severini A., Sinchi J.L., Šmahelová J., Tabrizi S.N., Tachezy R., Tohme Faybush S., Uloza V., Uloziene I., Wong Y.W., Židovec Lepej S., Burk R.D., Poljak M. (2016): Global genomic diversity of human papillomavirus type 11 (HPV11) based on 433 isolates and 78 complete genome sequences. J. Virol. 90 (11): 5503-5513. [PubMed]

Ragin C., Liu J.C., Jones G., Shoyele O^., Sowunmi B., Kennett R., Groen HJ., Gibbs D., Blackman E., Esan M., Brandwein M.S., Devarajan K., Bussu F., Chernock R., Chien C.Y., Cohen M.A., Samir E.M., Mikio S., D'Souza G., Funchain P., Eng C., Gollin S.M., Hong A., Jung Y.S., Krüger M., Lewis J., Jr., Morbini P., Landolfo S., Rittà M., Straetmans J., Szarka K., Tachezy R., Worden F.P., Nelson D., Gathere S., Taioli E. (2016): Prevalence of HPV infection in racial-ethnic subgroups of head and neck cancer patients. Carcinogenesis 38 (2): 218-229. [PubMed]

Rob F., Tachezy R., Pichlík T., Rob L., Kružicová Z., Hamšíková E., Šmahelová J., Hercogová J. (2016): High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts - Another reason for HPV vaccination of boys. Dermatol. Ther. 30 (1): e12435. [Wiley Online Library]

Sabol I., Šmahelová J., Klozar J., Mravak-Stipetic M., Gheit T., Tommasino M., Grce M., Tachezy R. (2016). Beta-HPV types in patients with head and neck pathology and in healthy subjects. J. Clinic. Virol. 82: 159-165. [Science Direct]

Saláková M., Košlabová E., Vojtěchová Z., Tachezy R., Šroller V. (2016): Detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues. J. Med. Virol. 88 (4): 695-702. [PubMed]

Šroller V., Hamšíková E., Ludvíková V., Musil J., Němečková Š., Saláková M. (2016): Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors. J. Med. Virol. 88 (7): 1254-1261. [PubMed]

Vojtěchová Z., Sabol I., Saláková M., Turek L., Grega M., Šmahelová J., Vencalek O., Lukešová E., Klozar J., Tachezy R. (2016): Analysis of the integration of human papillomaviruses in head and neck tumours in relation to patients' prognosis. Int. J. Cancer 138 (2): 386-395. [PubMed]

Vojtěchová Z., Sabol I., Saláková M., Šmahelová J., Zavadil J., Turek L., Grega M., Klozar J., Procházka B., Tachezy R. (2016): Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones. BMC Cancer  16: 382. [BioMedCentral]

2015

Hamšíková E., Tachezy R., Němečková Š. (2015): Prophylactic vaccines against human papillomaviruses: the potent tool for primary prevention of cervical cancer and possibly other tumors associated with HPV infection. In: Závadová E. (ed.): Onkologická imunologie, Mladá fronta a.s., Praha, pp. 89-102.

Partlová S., Bouček J., Kloudová K., Lukešová E., Zábrodský M., Grega M., Fučíková J., Truxová I., Tachezy R., Špíšek R., Fialová A. (2015): Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma. Oncoimmunology 4 (1): e965570. [PubMed]

Rob L., Tachezy R., Robová H. (2015): Cervical cancer: what is the optimal age for routine testing? Future Oncol. 11 (8): 1137-1140. [PubMed]

Sijmons S., Thys K., Mbong Ngwese M., Van Damme E., Dvořák J., Van Loock M., Li G., Tachezy R., Busson L., Aerssens J., Van Ranst M., Maes P. (2015): High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination. J. Virol. 89 (15): 7673–7695. [PubMed]

2014

Jelen M.M., Chen Z., Kocjan B.J., Burt F.J., Chan P.K., Chouhy D., Combrinck C.E., Coutlée F., Estrade C., Ferenczy A., Fiander A., Franco E.L., Garland S.M., Giri A.A., González J.V., Gröning A., Heidrich K., Hibbitts S., Hošnjak L., Luk T.N., Marinic K., Matsukura T., Neumann A., Oštrbenk A., Picconi M.A., Richardson H., Sagadin M., Sahli R., Seedat R.Y., Seme K., Severini A., Sinchi J.L., Šmahelová J., Tabrizi S.N., Tachezy R., Tohme S., Uloza V., Vitkauskiene A., Wong Y.W., Zidovec Lepej S., Burk R.D., Poljak M. (2014): Global genomic diversity of human papillomavirus 6 based on 724 isolates and 190 complete genome sequences. J. Virol.  88 (13): 7307-7316. [PubMed]

Klozar R., Tachezy R. (2014): What are the implications of human papillomavirus status in oropharyngeal tumors for clinical practice? Curr. Opin. Otolaryngol. Head Neck Surg. 22 (2): 90-94. [PubMed]

Lukešová E., Bouček J., Rotnáglová E., Saláková M., Košlabová E., Grega M., Eckschlager T., Říhová B., Procházka B.,  Klozar J., Tachezy R. (2014): High level of Tregs is a positive prognostic marker in patients with HPV-positive oral and oropharyngeal squamous cell carcinomas. Biomed. Res. Int.  2014: 303929. [PubMed]

Šroller V., Hamšíková E., Ludvíková V., Vochozková P., Kojzarová M., Fraiberk M., Saláková M., Morávková A., Forstová J., Němečková Š. (2014): Seroprevalence rates of BKV, JCV, and MCPyV 1 polyomaviruses in the general Czech Republic population. J. Med. Virol.  86 (9): 1560-1568. [PubMed]

2013

Fík Z., Valach J., Chovanec M., Mazánek J., Kodet R., Kodet O., Tachezy R., Foltynová E., André S., Kaltner H., Gabius H.J., Smetana K., Jr. (2013): Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas. J. Oral. Pathol. Med. 42 (2): 166-173. [PubMed]

Hamšíková E., Ludvíková V., Stašíková J., Tachezy R. (2013): Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic. Sex. Transm. Infect. 89 (2): 133-137. [PubMed]

Hrbáček J., Urban M., Hamšíková E., Tachezy R., Heráček J. (2013): Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review. Urol. Oncol. 31 (7): 951-965. [PubMed]

Klozar J., Košlabová E., Kratochvíl V., Saláková M., Tachezy R. (2013): Nodal status is not a prognostic factor in patients with HPV-positive oral/oropharyngeal tumors. J. Surg. Oncol. 107 (6): 625-633. [PubMed]

Košlabová E., Hamšíková E., Saláková M., Klozar J., Foltýnová E., Salková E., Rotnáglová E., Ludvíková V., Tachezy R. (2013): Markers of HPV infection and survival in patients with head and neck tumors. Int. J. Cancer 133 (8): 1832-1839. [PubMed]

Maver P.J., Seme K., Korać T., Dimitrov G., Döbrőssy L., Engele L., Iljazović E., Kesić V., Kostova P., Laušević D., Maurina A., Nicula F.A., Panayotova Y., Primic Žakelj M., Repše Fokter A., Romejko-Wolniewicz E., Smailytė G., Şuteu O., Świderska-Kiec J., Tachezy R., Valerianova Z., Veerus P., Vīberga I., Znaor A., Zubor P., Poljak M. (2013): Cervical cancer screening practices in central and eastern Europe in 2012. Acta Dermatovenerol. Alp. Panonica Adriat. 22 (1): 7-19. [PubMed]

Tachezy R., Šmahelová J., Kašpírková J., Saláková M. (2013): Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One 8 (11): e79156. [PubMed]

2012

Petráčková M., Tachezy R., Vonka V. (2012): Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 (IL-2) and granulocyte-macrophage colony stimulating factor (GM- CSF) I. Derivation, genetic stability, oncogenicity and immunogenicity. Int. J. Oncol. 40 (5): 1668-1676. [PubMed]

Tachezy R., Hrbáček J., Heráček J., Saláková M., Šmahelová J., Ludvíková V., Švec A., Urban M., Hamšíková E. (2012): HPV persistence and its oncogenic role in prostate tumors. J. Med. Virol. 84 (10): 1636-1645. [PubMed]

2011

Hrbáček J., Urban M., Hamšíková E., Tachezy R., Eis V., Brabec M., Heráček J. (2011): Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer 11: 53. [PubMed]

Rotnáglová E., Tachezy R., Saláková M., Procházka B., Košľabová E., Veselá E., Ludvíková V., Hamšíková E., Klozar J. (2011): HPV infection in tonsillar cancer: prognostic significance and clinically relevant markers. Int. J. Cancer 129 (1): 101-110. [PubMed]

Tachezy R., Šmahelová J., Saláková M., Arbyn M., Rob L., Škapa P., Jirásek P., Hamšíková E. (2011): Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One 6 (7): e21913. [PubMed]

2010

Klozar J., Tachezy R., Rotnáglová E., Košlabová E., Saláková M., Hamšíková E. (2010): Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects. Wien Med. Wochenschr. 160 (11-12): 305-309. [PubMed]

2009

Anttila A., Ronco G., Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer  (EUNICE) (2009): Description of the national situation of cervical cancer screening in the member states of the European Union. Eur. J. Cancer 45 (15): 2685-2708. [PubMed]

Klug S.J., Ressing M., Koenig J., Abba M.C., Agorastos T., Brenna S.M., Ciotti M., Das B.R., Del Mistro A., Dybikowska A., Giuliano A.R., Gudleviciene Z., Gyllensten U., Haws A.L., Helland A., Herrington C.S., Hildesheim A., Humbey O., Jee S.H., Kim J.W., Madeleine M.M., Menczer J., Ngan H.Y., Nishikawa A., Niwa Y., Pegoraro R., Pillai M.R., Ranzani G., Rezza G., Rosenthal A.N., Roychoudhury S., Saranath D., Schmitt V.M., Sengupta S., Settheetham-Ishida W., Shirasawa H., Snijders P.J., Stoler M.H., Suárez-Rincón A.E., Szarka K., Tachezy R., Ueda M., van der Zee A.G., von Knebel Doeberitz M., Wu M.T., Yamashita T., Zehbe I., Blettner M. (2009): TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 10 (8): 772-784. [PubMed]

Lučanský V., Sobotková E., Tachezy R., Dušková M., Vonka V. (2009): DNA vaccination against bcr-abl-positive cells in mice. Int. J. Oncol. 35 (4): 941-951. [PubMed]

Nicula F.A., Anttila A., Neamtiu L., Zakelj M.P., Tachezy R., Chil A., Grce M., Kesić V. (2009): Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur. J. Cancer 45 (15): 2679-2684. [PubMed]

Sobotková E., Dušková M., Tachezy R., Petráčková M., Vonka V. (2009): Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells. Oncol. Rep. 21 (3): 793-799. [PubMed]

Saláková M., Němeček V., Tachezy R. (2009): TTV and HPV co-infection in cervical smears of patients with cervical lesions. BMC Infect. Dis. 9: 118. [PubMed]

Tachezy R., Klozar J., Rubenstein L., Smith E., Saláková M., Šmahelová J., Ludvíková V., Rotnáglová E., Kodet R., Hamšíková E. (2009): Demographic and risk factors in patients with head and neck tumors. J. Med. Virol. 81 (5): 878-887. [PubMed]

2008

Klozar J., Kratochvíl V., Saláková M., Šmahelová J., Veselá E., Hamšíková E., Betka J., Tachezy R. (2008): HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur. Arch Otorhinolaryngolog. 265 (Suppl. 1): S75-S82. [PubMed]

Klozar J., Zábrodský M., Mudrová E., Hamšíková E., Saláková M., Šmahelová J., Tachezy R. (2008): The Role of HPV as a Risk and Prognostic Factor in Head and Neck Squamous Cell Carcinoma. Centr. Eur. J. Publ. Health 16 (Suppl.): S40-S41. [CEJPH]

Sabol I., Saláková M., Šmahelová J., Pawlita M., Schmitt M., Gašperov N.M., Grce M., Tachezy R. (2008): Evaluation of different techniques for identification of human papillomavirus types of low prevalence. J. Clin. Microbiol. 45 (5): 1606-1613. [PubMed]

Tachezy R., Davies P., Arbyn M., Rob L., Lazdane G., Petrenko J., Hamšíková E., Beková A., Klozar J., Dušková J. (2008): Consensus recomendations for cervical cancer prevention in the Czech Republic: a report of the International Conference on Human Papillomavirus in Human Pathology (Prague, 1-3 May 2008). J. Med. Screen. 15 (4): 207-210. [PubMed]

Tachezy R., Hamšíková E., Šmahelová J. (2008): Cervical cancer screening in the Czech Republic. Centr. Eur. J. Publ. Health 16 (Suppl.): S31-S32. [CEJPH]

2007

Lacina L., Dvořánková B., Smetana K., Jr., Chovanec M., Plzák J., Tachezy R., Kideryová L., Kučerová L., Čada Z., Bouček J., Kodet R., Andre S., Gabius H.J. (2007): Marker profiling of normal keratinocytes identifies the stroma from squamous cellcarcinoma of the oral cavity as a modulatory microenvironment in co-culture. Int. J. Radiat. Biol. 83 (11-12): 837-848. [PubMed]

Rector A., Lemey P., Tachezy R., Mostmans S., Ghim S.J., Van Doorslaer K., Roelke M., Bush M., Montali R.J., Joslin J., Burk R.D., Jenson A.B., Sundberg J.P., Shapiro B., Van Ranst M. (2007): Ancient papillomavirus-host co-speciation in Felidae. Genome Biol. 8 (4): R57. [PubMed]

Robová H., Rob L., Pluta M., Kačírek J., Slavík V., Škapa P., Hamšíková E., Tachezy R. (2007): Progression and regression low grade intraepitelial squamous lesions in context of positivity of high risk human papillomavirus. Česká Gynekol. 72 (5): 347-350. [PubMed]

Škapa P., Zámečník J., Hamšíková E., Saláková M., Šmahelová J., Jandová K., Robová H., Rob L., Tachezy R. (2007): Human papillomavirus (HPV) profiles of vulvar lesions. Possible implications for the classification of vulvar squamous cell carcinoma precursors and for the efficacy of prophylactic HPV vaccination. Am. J. Surg. Pathol. 31 (12): 1834-1843. [PubMed]

Tachezy R., Jirásek T., Saláková M., Ludvíková V., Kubecová M., Horák L., Mandys V., Hamšíková E. (2007): Human papillomavirus infection and tumours of the anal canal: correlation of histology, PCR detection in paraffin sections and serology. APMIS 115 (3): 195-203. [PubMed]

Tachezy R., Šmahelová J. (2007): Quality assurance of human papillomavirus testing. Coll. Antropol. 31 (Suppl 2): 61-65. [SRCE]

Tachezy R., Rob L. (2007): Cervical cancer screening in the Czech Republic. Coll. Antropol. 31 (Suppl 2): 27-29. [SRCE]

2006

Tachezy R., Mikysková I., Ludviková V., Rob L., Kučera T., Slavík V., Bekova A., Robová H., Pluta M., Hamšíková E. (2006): Longitudinal study of patients after surgical treatment for cervical lesions: HPV DNA detection and prevalence of HPV–specific antibodies. Eur. J. Clin. Microbiol. Infect. Dis. 25 (8): 492-500. [PubMed]

2005

Rector A., Tachezy R., Van Doorslaer K., MacNamara T., Burk R.D., Sundberg J.P., Van Ranst M. (2005): Isolation and cloning of a papillomavirus from a North American porcupine by using multiply primed rolling-circle amplification: the Erethizon dorsatum papillomavirus type 1. Virology 331 (2): 449-456. [PubMed]

Šmahel M., Šmahelová J., Tejklová P., Tachezy R., Jelínek F. (2005): Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras. Oncol. Rep. 14 (6): 1665-1674. [PubMed]

Šmahel M., Šmahelová J., Tejklová P., Tachezy R., Marinov I. (2005): Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein. Int. J. Oncol. 27 (3): 731-742. [PubMed]

Tachezy R., Klozar J., Saláková M., Smith E., Turek L., Betka J., Kodet R., Hamšíková E. (2005): HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral. Dis. 11 (3): 181-185. [PubMed]

Jelínek F., Tachezy R. (2005): Cutaneous papillomatosis in cattle. J. Comp. Pathol. 132 (1): 70-81. [PubMed]

2004

Rector A., Tachezy R., Van Ranst M. (2004): A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J. Virol. 78 (10): 4993-4998. [PubMed]

Saláková M., Němeček V., König J., Tachezy R. (2004): Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic. BMC Infect. Dis. 4 (1): 56. [PubMed]

2003

Švec A., Mikysková I., Hes O., Tachezy R. (2003): Human papillomavirus infection of the epididymis and ductus deferens: an evaluation by nested polymerase chain reaction. Arch. Pathol. Lab. Med. 127 (11): 1471-1474. [PubMed]

Tachezy R., Saláková M, Hamšíková E, Kaňka J., Havránková A., Vonka V. (2003): Prospective study on cervical neoplasia: presence of HPV DNA in cytological smears precedes the development of cervical neoplastic lesions. Sex. Transm. Infect. 79 (3): 191-196. [PubMed]

2002

Tachezy R., Duson G., Rector A., Jenson A.B., Sundberg J.P., Van Ranst M. (2002): Cloning and genomic characterization of Felis domesticus papillomavirus type 1. Virology 301 (2): 313-321. [PubMed]

Tachezy R., Rector A., Havelková M., Wollants E., Fiten P., Opdenakker G., Jenson B., Sundberg J., Van Ranst M. (2002): Avian papillomaviruses: the parrot Psittacus erithacus papillomavirus (PePV) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus. BMC Microbiol. 10 (2): 19. [PubMed]

Tachezy J., Tachezy R., Hampl V., Šedinová M., Vanáčová S., Vrlik M., Van Ranst M., Flégr J., Kulda J. (2002): Cattle pathogen Tritrichomonas foetus (Riedmuller, 1928) and pig commensal Tritrichomonas suis (Gruby & Delafond, 1843) belong to the same species. J. Eukaryot. Microbiol. 49 (2): 154-163. [PubMed]

2001

Zehbe I., Tachezy R., Mytilineos J., Voglino G., Mikysková I., Delius H., Marongiu A., Gissmann L., Wilander E., Tommasino M. (2001): Human papillomavirus 16 E6 polymorphisms in cervical lesions from different  European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer. 94 (5): 711-716. [PubMed]

2000

Hamšíková E., Ludvíková V., Tachezy R., Kovařík J., Brousková L., Vonka V. (2000): Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int. J. Cancer 86 (3): 351-355. [PubMed]

1999

Švec A., Urban M., Mikysková I., Tachezy R. (1999): Human papillomavirus in squamous metaplastic epithelium with dysplasia of the epididymis detected by PCR method. Am. J. Surg. Pathol. 23 (11): 1437-1438. [PubMed]

Tachezy R., Hamšíková E., Hájek T., Mikysková I., Šmahel M., Van Ranst M., Kaňka J., Havranková A., Rob L., Guttner V., Slavík V., Anton M., Kratochvíl B., Kotrsová L., Vonka V. (1999): Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J. Med. Virol. 58 (4): 378-386. [PubMed]

Tachezy R., Mikysková I., Saláková M., Van Ranst M. (1999): Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism. Human Genet. 105 (6): 564-566. [PubMed]

1996

Van Ranst M., Tachezy R., Burk R.D. (1996): Human papillomaviruses: A never ending story? In: Lacey C. (ed.): Papillomavirus Reviews: Current Research on Papillomaviruses.  Royal Society of Medicine Services Ltd., Leeds University Press, pp. 1-20.

Van Ranst M., Tachezy R., Delius H., Burk R.D. (1996): Classification of the human papillomaviruses based on their molecular evolutionary relationship. In: Von Krogh G., Gross G. (eds.): Human papillomaviruse infection in dermatovenereology. CRC Press, Inc., Florida, U.S.A.

1995

Ho G.Y., Burk R.D., Klein S., Kadish A.S., Chang C.J., Palan P., Basu J., Tachezy R., Lewis R., Romney S. (1995): Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer Inst. 87 (18): 1365-1371. [PubMed]

Wadler S., Burk R.D., Neuberg D., Rameau R., Runowicz C.D., Goldberg G., McGill F., Tachezy R., Comis R., Edmonson J., Wiernik P.H. (1995): Lack of efficacy of interferon-alpha therapy in recurrent, advanced cervical cancer. J. Interferon. Cytokine. Res. 15 (12): 1011-1016. [PubMed]